Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CHECKPOINT INHIBITORS

Journal of Experimental Medicine (JEM)

Microbiome Influencers of Checkpoint Blockade–associated Toxicity

Oncology, Medical January 23rd 2023

The New England Journal of Medicine

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Oncology, Medical January 23rd 2023

The New England Journal of Medicine

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Hematology January 17th 2023

The New England Journal of Medicine

Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer

Oncology, Medical January 17th 2023

MedPage Today

Crystal Ball Cloudy for PI3K Inhibitors’ Future in Hematology

Hematology January 9th 2023

OBR Oncology

Mantle Cell Lymphoma: Optimizing Current Therapies

Oncology, Medical January 3rd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form